{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:23:50Z","timestamp":1778826230781,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001785","name":"Flinders University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.humpath.2020.08.005","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:23:57Z","timestamp":1599002637000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3252-2519","authenticated-orcid":false,"given":"Sarita","family":"Prabhakaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashleigh","family":"Hocking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6054-0605","authenticated-orcid":false,"given":"Chankyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8976-4714","authenticated-orcid":false,"given":"Sonja","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.08.005_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"World health organization committee for tumors of the P. The 2015 world health organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.humpath.2020.08.005_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2020.08.005_bib3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/modpathol.2009.180","article-title":"Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases","volume":"23","author":"Klebe","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.07.015","article-title":"The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center","volume":"67","author":"Marchevsky","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.it.2014.04.002","article-title":"GATA3: a master of many trades in immune regulation","volume":"35","author":"Wan","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.humpath.2020.08.005_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.humpath.2012.09.010","article-title":"GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance","volume":"44","author":"Gonzalez","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.humpath.2017.04.003","article-title":"GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator","volume":"64","author":"Inoue","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PAT.0000000000000250","article-title":"Loss of expression of BAP1 predicts longer survival in mesothelioma","volume":"47","author":"Farzin","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2020.08.005_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/gcc.22381","article-title":"Different prognostic roles of tumor suppressor gene BAP1 in cancer: a systematic review with meta-analysis","volume":"55","author":"Luchini","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2020.08.005_bib12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/PAS.0000000000000825","article-title":"GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung","volume":"41","author":"Berg","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib13","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.5858\/arpa.2014-0061-RA","article-title":"Immunohistochemistry in undifferentiated neoplasm\/tumor of uncertain origin","volume":"138","author":"Lin","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2020.08.005_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib15","series-title":"Utility of immunohistochemistry for MUC4 and GATA3 to aid in the distinction of sarcomatoid mesothelioma from sarcomatoid carcinoma","author":"Terra","year":"2019"},{"key":"10.1016\/j.humpath.2020.08.005_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.humpath.2015.09.015","article-title":"GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas","volume":"47","author":"Davis","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib17","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.21037\/jtd.2017.10.125","article-title":"The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review","volume":"10","author":"Ali","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.humpath.2020.08.005_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ajcp\/144.suppl2.093","article-title":"Expression of GATA-3 in benign mesothelial cells","volume":"144","author":"Ramirez","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156524","article-title":"GATA3 expression is a poor prognostic factor in soft tissue sarcomas","volume":"11","author":"Haraguchi","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.humpath.2020.08.005_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1600-0463.2012.02908.x","article-title":"Limitations of tissue micro array in Duke's B colon cancer","volume":"120","author":"Kjaer-Frifeldt","year":"2012","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2020.08.005_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/COC.0b013e3182a0e867","article-title":"Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma","volume":"38","author":"Pillai","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.humpath.2020.08.005_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PAT.0b013e328342016c","article-title":"Validation of tissue microarray technology in malignant pleural mesothelioma","volume":"43","author":"Kao","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2020.08.005_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/modpathol.3800736","article-title":"D2-40 and calretinin\u2014a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation","volume":"20","author":"Hinterberger","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib24","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.athoracsur.2014.04.040","article-title":"Women with malignant pleural mesothelioma have a threefold better survival rate than men","volume":"98","author":"Taioli","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.humpath.2020.08.005_bib25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.humpath.2014.03.006","article-title":"Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study","volume":"45","author":"Ordonez","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12672-013-0138-x","article-title":"GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness","volume":"4","author":"Gaynor","year":"2013","journal-title":"Horm Canc"},{"key":"10.1016\/j.humpath.2020.08.005_bib27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/med.21362","article-title":"The significance and therapeutic potential of GATA3 expression and mutation in breast cancer: a systematic review","volume":"35","author":"Du","year":"2015","journal-title":"Med Res Rev"},{"key":"10.1016\/j.humpath.2020.08.005_bib28","first-page":"1954","article-title":"Immunohistochemical biomarkers in biphasic malignant mesothelioma: a multi-institutional analysis. Abstracts from USCAP 2020: pulmonary, mediastinum, pleura, and peritoneum pathology (1869-1980)","volume":"33","author":"Schulte","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib30","doi-asserted-by":"crossref","first-page":"1310478","DOI":"10.1155\/2017\/1310478","article-title":"Malignant mesothelioma, BAP1 immunohistochemistry, and VEGFA: does BAP1 have potential for early diagnosis and assessment of prognosis?","volume":"2017","author":"Pulford","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.humpath.2020.08.005_bib31","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.humpath.2013.05.022","article-title":"Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and\/or hormonal therapy and clinicopathologic features of GATA-3-positive tumors","volume":"44","author":"Gulbahce","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.08.005_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/his.12625","article-title":"GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups","volume":"67","author":"Ni","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.08.005_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/1055-9965.EPI-06-1090","article-title":"GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value","volume":"17","author":"Voduc","year":"2008","journal-title":"Canc Epidemiol Biomarkers Prev"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:37:10Z","timestamp":1758645430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720301672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":33,"alternative-id":["S0046817720301672"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.08.005","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}